KRAS and pancreatic neoplasm: In addition, S Jagadeeshan et al. illustrated that Pak1–NF-kB–p65-mediated FN1 regulation is a potent tumor-promoting mechanism in pancreatic cancer cell mode without KRAS mutations [48].